IMAAVY
IMAAVY
IMAAVY™ (nipocalimab-aahu) is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients 12 years of age and older who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.
Treatment has shown to help improve neuromuscular communication, resulting in stronger muscles and better daily functioning for patients managing gMG.
Administration Information
IMAAVY is administered through an intravenous (IV) infusion. After your initial dose, you will receive an infusion once every 2 weeks lasting 15-30 minutes.
Potential Side Effects
The most common side effects in people with gMG treated with IMAAVY include:
● infection in parts of your body that you use for breathing (respiratory tract infection)
● swelling in your hands, ankles, or feet (peripheral edema)
● muscle spasms
For a list of all potential side effects:
https://www.imaavy.com/generalized-myasthenia-gravis/about-imaavy/#side-effects-and-safety
Helpful Resources
What is GMG?
About Imaavy:
About Infusions:
Savings and Support:
MG treatment tips
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Patient Consent Form
HIPAA Privacy Authorization Form
Notice of Privacy Practices
Patient Rights and Responsibilities
Appointment Lateness and Cancelation
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP
Southwest Florida
Tampa Bay